Evogene Ltd.EVGNNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+72.5%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+72.5%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
5.1x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 170.97% |
| Q2 2025 | -63.16% |
| Q1 2025 | -705.10% |
| Q4 2024 | 104.79% |
| Q3 2024 | -23.58% |
| Q2 2024 | -39.47% |
| Q1 2024 | 41.54% |
| Q4 2023 | -60.49% |
| Q3 2023 | 47.74% |
| Q2 2023 | -2.65% |
| Q1 2023 | -1977.03% |
| Q4 2022 | 54.56% |
| Q3 2022 | 33.33% |
| Q2 2022 | -9.09% |
| Q1 2022 | -22.22% |
| Q4 2021 | 5.26% |
| Q3 2021 | -26.67% |
| Q2 2021 | 11.76% |
| Q1 2021 | 29.17% |
| Q4 2020 | -33.33% |
| Q3 2020 | -12.50% |
| Q2 2020 | 33.33% |
| Q1 2020 | 0.00% |
| Q4 2019 | -50.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | -14.29% |
| Q1 2019 | 39.13% |
| Q4 2018 | -21.05% |
| Q3 2018 | 0.00% |
| Q2 2018 | 9.52% |
| Q1 2018 | 12.50% |
| Q4 2017 | -20.00% |
| Q3 2017 | -11.11% |
| Q2 2017 | 5.26% |
| Q1 2017 | 26.92% |
| Q4 2016 | -30.00% |
| Q3 2016 | -11.11% |
| Q2 2016 | -38.46% |
| Q1 2016 | 40.91% |
| Q4 2015 | -69.23% |